ASTS
AST SpaceMobile, Inc.
ASTS has lower modeled downside risk, despite its lower overall score.
MSGM
Motorsport Games Inc.
MSGM has the edge over ASTS overall, supported by stronger fundamentals.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MSGM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
MSGM's revenue, profitability, cash flow and balance sheet are all currently healthy.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
MSGM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.7x | $0.25 | -94% |
| Fair | 3.5x | $1.17 | -73% |
| Current | 13x | $4.28 | — |
| Expensive | 33x | $11.12 | +160% |
Historical ranges are pointers, not guarantees.
MSGM's PE is in its expensive range at 13x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MSGM Forward outlook
There aren't enough analyst estimates for MSGM to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
MSGM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | +325% |
| Q2 2026 | $0.42 | +$0.48 |
| Q1 2026 | $1.16 | +$1.17 |
| Q4 2025 | $1.43 | +$2.37 |
| Q3 2025 | $0.08 | -96% |
| Q2 2025 | -$0.06 | -111% |
| Q1 2025 | -$0.01 | +$3.32 |
| Q4 2024 | -$0.94 | +$4.14 |
MSGM has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over MSGM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
MSGM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.8M | +22% |
| Q2 2026 | $3.5M | +37% |
| Q1 2026 | $4M | +129% |
| Q4 2025 | $3.8M | +95% |
| Q3 2025 | $3.1M | +72% |
| Q2 2025 | $2.6M | +38% |
| Q1 2025 | $1.8M | -42% |
| Q4 2024 | $2M | +13% |
MSGM's revenue is recovering but still below its 2020 peak: $4M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | +6.5 points |
| Q2 2026 | 18% | -58 points |
| Q1 2026 | 26% | +32 points |
| Q4 2025 | 15% | +48 points |
| Q3 2025 | 26% | +133 points |
| Q2 2025 | 76% | -34 points |
| Q1 2025 | -5.3% | +35 points |
| Q4 2024 | -34% | +122 points |
MSGM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
MSGM has the stronger cash trend. Its trailing FCF is up 157% versus its history, compared with ASTS at down 363%.
MSGM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $1.6M | +433% |
| Q4 2025 | $1.7M | +$3.9M |
| Q4 2024 | -$2.1M | +$674.5K |
| Q3 2024 | $671.8K | +$1.9M |
| Q4 2023 | -$2.8M | -$193.2K |
| Q3 2023 | -$1.3M | +$3.7M |
| Q2 2023 | -$3.2M | +$3.4M |
| Q1 2023 | -$5.7M | -$8.6K |
MSGM's free cash flow has turned positive after five years mostly in the red: $6M over the past year.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
MSGM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +110K shares |
| 1 year | -1.7% | -91K shares |
| 3 years | +97% | +2.6M shares |
| 5 years | +361% | +4.2M shares |
| Available history | +216% | +3.7M shares |
MSGM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2020 | — |
| Q3 2020 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MSGM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 22.6x | High |
| Q1 2025 | 19.3x | High |
| Q4 2020 | 8.2x | High |
| Q3 2020 | 3.7x | Elevated |
MSGM has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
MSGM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 44.7 | Neutral |
MSGM's weekly RSI is 49 (neutral) and its Stochastic is 45 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
MSGM PE vs Technology Sector
| Metric | MSGM | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 28x | 55% below |
| PE % | 78 | 40 | 38 pts above |
MSGM is trading at 13x earnings, a 55% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
MSGM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.74 | 9.7% below |
| 20 week MA | $4.51 | 5.1% below |
| 50 week MA | $4.10 | 4.4% above |
| 100 week MA | $3.20 | 34% above |
| 200 week MA | $3.35 | 28% above |
MSGM has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
MSGM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $300.0 | $40.3 | -87% |
| 2022 | $40.3 | $2.67 | -93% |
| 2023 | $2.67 | $3.09 | +16% |
| 2024 | $3.09 | $1.23 | -60% |
| 2025 | $1.23 | $3.16 | +157% |
| 2026 YTD | $3.16 | $4.28 | +35% |
MSGM has the edge over ASTS on returns for 2026, with the stronger performance.